“I want you [employers] to be the drivers of change,” said Heather Sundar, Pharm.D., senior vice president consulting and employer solutions at Archimedes. Sundar spoke at The Alliance’s September 2018 Annual Meeting about the risks and opportunities presented by specialty drugs and biosimilars.
Culture change is never easy. But now is the time for employers to increase awareness about opioid abuse and implement prevention and treatment options to support their employees (and loved ones too!).
Two medical doctors, a pharmaceutical researcher and a pharmacist were among the speakers invited to share their insights at The Alliance’s Opioid Epidemic Summit, held at the Monona Terrace in Madison, Wis.
“How do you talk to someone who is an addict? Use honesty. Don’t overcomplicate this.” Those were the words of advice from Robert Poznanovich, vice president at Hazelden Betty Ford Foundation. Poznanovich was one of several speakers at The Alliance’s Opioid Epidemic event. The speakers offered strategies for employers to reduce stigma and address opioid addiction in the workplace.
“There is strength in numbers – in policy making as well as purchasing health care,” said Karen Timberlake, principal at the Wisconsin offices of Michael Best Strategies. Several staff members of Michael Best Strategies spoke about the past year in health policy and what lies ahead in 2018 at The Alliance’s Health Policy event.